SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-026680
Filing Date
2021-05-17
Accepted
2021-05-17 07:40:52
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_silopharma.htm 10-Q 495510
2 CERTIFICATION f10q0321ex31-1_silopharma.htm EX-31.1 10902
3 CERTIFICATION f10q0321ex32-1_silopharma.htm EX-32.1 4864
  Complete submission text file 0001213900-21-026680.txt   3220984

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE silo-20210331.xml EX-101.INS 377236
5 XBRL SCHEMA FILE silo-20210331.xsd EX-101.SCH 60546
6 XBRL CALCULATION FILE silo-20210331_cal.xml EX-101.CAL 31712
7 XBRL DEFINITION FILE silo-20210331_def.xml EX-101.DEF 221601
8 XBRL LABEL FILE silo-20210331_lab.xml EX-101.LAB 402486
9 XBRL PRESENTATION FILE silo-20210331_pre.xml EX-101.PRE 231070
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54872 | Film No.: 21927588
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl